These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 3145062)

  • 1. Coronary flow reserve and the J curve relation between diastolic blood pressure and myocardial infarction.
    Cruickshank JM
    BMJ; 1988 Nov; 297(6658):1227-30. PubMed ID: 3145062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relation of low diastolic blood pressure to coronary heart disease death in presence of myocardial infarction: the Framingham Study.
    D'Agostino RB; Belanger AJ; Kannel WB; Cruickshank JM
    BMJ; 1991 Aug; 303(6799):385-9. PubMed ID: 1912805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of coronary perfusion pressure.
    Cruickshank JM
    Eur Heart J; 1992 Sep; 13 Suppl D():39-43. PubMed ID: 1396858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coronary flow reserve and the J curve.
    BMJ; 1988 Dec; 297(6663):1606-8. PubMed ID: 3147093
    [No Abstract]   [Full Text] [Related]  

  • 5. Antihypertensive treatment, myocardial infarction, and nocturnal myocardial ischaemia.
    Floras JS
    Lancet; 1988 Oct; 2(8618):994-6. PubMed ID: 2902496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. J curve in antihypertensive therapy--does it exist? A personal point of view.
    Cruickshank JM
    Cardiovasc Drugs Ther; 1994 Oct; 8(5):757-60. PubMed ID: 7873473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of myocardial diastolic dysfunction on coronary flow reserve in hypertensive patients with left ventricular hypertrophy.
    Galderisi M; Cicala S; De Simone L; Caso P; Petrocelli A; Pietropaolo L; Celentano A; Mininni N; de Divitiis O
    Ital Heart J; 2001 Sep; 2(9):677-84. PubMed ID: 11666096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No evidence for a J-shaped curve in treated hypertensive patients with increased cardiovascular risk: The VALUE trial.
    Kjeldsen SE; Berge E; Bangalore S; Messerli FH; Mancia G; Holzhauer B; Hua TA; Zappe D; Zanchetti A; Weber MA; Julius S
    Blood Press; 2016; 25(2):83-92. PubMed ID: 26511535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Impact of Left Ventricular Mass on Diastolic Blood Pressure Targets for Patients With Coronary Artery Disease.
    Rabkin SW; Shiekh IA; Wood DA
    Am J Hypertens; 2016 Sep; 29(9):1085-93. PubMed ID: 27312942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coronary microvascular dysfunction after myocardial infarction: increased coronary zero flow pressure both in the infarcted and in the remote myocardium is mainly related to left ventricular filling pressure.
    Van Herck PL; Carlier SG; Claeys MJ; Haine SE; Gorissen P; Miljoen H; Bosmans JM; Vrints CJ
    Heart; 2007 Oct; 93(10):1231-7. PubMed ID: 17395671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypertension and coronary artery disease: epidemiology, physiology, effects of treatment, and recommendations : A joint scientific statement from the Austrian Society of Cardiology and the Austrian Society of Hypertension.
    Weber T; Lang I; Zweiker R; Horn S; Wenzel RR; Watschinger B; Slany J; Eber B; Roithinger FX; Metzler B
    Wien Klin Wochenschr; 2016 Jul; 128(13-14):467-79. PubMed ID: 27278135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The J-curve in hypertension.
    Cruickshank J
    Curr Cardiol Rep; 2003 Nov; 5(6):441-52. PubMed ID: 14558984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Lowering Diastolic Pressure in Patients With and Without Cardiovascular Disease: Analysis of the SPRINT (Systolic Blood Pressure Intervention Trial).
    Khan NA; Rabkin SW; Zhao Y; McAlister FA; Park JE; Guan M; Chan S; Humphries KH
    Hypertension; 2018 May; 71(5):840-847. PubMed ID: 29581214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Control of blood pressure and risk of first acute myocardial infarction: Skaraborg hypertension project.
    Lindblad U; Råstam L; Rydén L; Ranstam J; Isacsson SO; Berglund G
    BMJ; 1994 Mar; 308(6930):681-6. PubMed ID: 8142790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The J-curve between blood pressure and coronary artery disease or essential hypertension: exactly how essential?
    Messerli FH; Panjrath GS
    J Am Coll Cardiol; 2009 Nov; 54(20):1827-34. PubMed ID: 19892233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inverse relation between diastolic blood pressure and long-term outcomes in patients undergoing pharmacoinvasive therapy for myocardial infarction: the J-shaped relation in the contemporary era of revascularisation.
    Lee CH; Foo D; Wong HB; Hong EC; Seow SC; Ng KS; Lim YT; Tan HC
    J Cardiovasc Med (Hagerstown); 2006 Nov; 7(11):806-11. PubMed ID: 17060806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative analysis of cardiac function, geometry, energetics and coronary reserve in hypertensive heart disease.
    Strauer BE
    Nephron; 1987; 47 Suppl 1():76-86. PubMed ID: 2962004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antihypertensive treatment and the J-curve.
    Cruickshank JM
    Cardiovasc Drugs Ther; 2000 Aug; 14(4):373-9. PubMed ID: 10999643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Goals of antihypertensive therapy. Is there a point beyond which pressure reduction is dangerous?
    Berglund G
    Am J Hypertens; 1989 Jul; 2(7):586-93. PubMed ID: 2667576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of lowering blood pressure to prevent stroke versus to prevent coronary events.
    Chrysant SG; Chrysant GS
    Am J Cardiol; 2010 Sep; 106(6):825-9. PubMed ID: 20816123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.